Showing results (31-40 of 81) with videos related to
Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|January 23, 2022
Dose-dependent bioavailability and tissue distribution of the ATR inhibitor AZD6738 (ceralasertib) in miceBrian F Kiesel, Jianxia Guo, Robert A Parise, et al.Biorxiv : the Preprint Server for Biology|August 6, 2025
Uracil-DNA glycosylase deficiency is associated with repressed tumor cell-intrinsic inflammatory signaling and altered sensitivity to exogenous interferonsFrank P Vendetti, Pinakin Pandya, Carina R Sclafani, et al.DNA Repair|June 10, 2019
Quantitative analysis of ATM phosphorylation in lymphocytesChristopher J Bakkenist, R Kenneth Czambel, Yan Lin, et al.Oncotarget|August 1, 2013
Radiation therapy induces the DNA damage response in peripheral bloodChristopher J Bakkenist, R Kenneth Czambel, David A Clump, et al.Cancer Chemotherapy and Pharmacology|May 4, 2022
Dose-dependent bioavailability, absorption-rate limited elimination, and tissue distribution of the ATR inhibitor BAY-1895344 (elimusertib) in miceBrian F Kiesel, Joshua J Deppas, Jianxia Guo, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2014
Simian virus 40 large T antigen induces IFN-stimulated genes through ATR kinaseAdriana Forero, Nicholas S Giacobbi, Kevin D McCormick, et al.Journal of Pharmaceutical and Biomedical Analysis|February 19, 2017
LC-MS/MS assay for the simultaneous quantitation of the ATM inhibitor AZ31 and the ATR inhibitor AZD6738 in mouse plasmaBrian F Kiesel, Jeffrey C Shogan, Madani Rachid, et al.Cell Cycle (Georgetown, Tex.)|April 23, 2005
ATM activation in normal human tissues and testicular cancerJirina Bartkova, Christopher J Bakkenist, Ewa Rajpert-De Meyts, et al.Plos Pathogens|January 29, 2021
Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in miceAlexandra I Wells, Kalena A Grimes, Kenneth Kim, et al.Gynecologic Oncology|January 7, 2015
Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cellsPang-ning Teng, Nicholas W Bateman, Kathleen M Darcy, et al.Pageof 9